Sign Up to like & get
recommendations!
0
Published in 2025 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae631.1741
Abstract: Abstract Background Per FDA Guidance, the primary efficacy endpoint for trials evaluating antimicrobials for treatment of UTI is a combined clinical/microbiologic response. Overall success requires both resolution of UTI symptoms and demonstration that the causative…
read more here.
Keywords:
therapeutics stocks;
iterum therapeutics;
treatment;
clinical failure ... See more keywords